Brazil Infection Control Market - Forecasts from 2020 to 2025
Brazil infection control market is projected to grow at a CAGR of 7.80% during the forecast period.. The most commonly acquired infections during the treatment in the hospital or while undergoing healthcare procedures or with going healthcare procedures in untidy and germ prone environments are called as Healthcare-acquired infections (HAI’s). According to a study conducted in Brazil, the hospital-associated infections pose a serious problem to patient safety as they lead to the increased chances of the patient of being subjected to the dangers of contracting deadly viruses, so it is important to follow efficient and proper cleanliness practices of surfaces and instrument so as to orient infections. Therefore, this has resulted in an increased demand for infection control in the Brazilian hospitals, is leading to a surge in the market growth presently, and is going to continue to do over the forecast period and beyond.
However, the lack of complete awareness and the technical know-how of the effective methods that are needed to efficiently disinfect the surroundings and sterilize the instruments to be used in the operative procedures on different individuals poses a serious health problem and puts other at risk, thereby acting as a limiting factor in the market growth over the forecast period.
Furthermore, the market players are increasingly participating and involved in the market through top-quality and enhanced product offerings in order to cater to the rising demand among the consumers effectively and to contribute to the growth of the market over the forecast period. For instance, B. Braun Melsungen AG, one of the companies dealing in the provision of and based in offering their range of infection control products. They offer products under the “Fast-acting alcoholic disinfectant” and “Fixed surface disinfectant”, which are a part of their Surface Disinfectant product line. The fast-acting alcoholic disinfectant product is called the “Meliseptol Foam pure” and is designed to be a pure hospital disinfectant for surfaces that are fixed and non-critical articles, which are able to show a broad spectrum of antimicrobial action. Some of the other features of this product are, that s is ready to use for all the safety and medical equipment, it is active against the bacteria, mycobacteria, fungi, viruses such as HIV, HBV or HCV, adenovirus, noro-polyomavirus and rotavirus. The product “Virkon” is sold under the fixed surface disinfectant and is advised to be used at 1%. The product is designed with a unique formula, is in powder form and is able to facilitate the effective removal of organic matter and bacteria and is also capable to clean the bodily fluids and cleans up to 99.99% microorganisms.
Disinfectant to show notable growth
Disinfectants are expected to hold a significant market share and show notable growth over the forecast period. This is attributable to the fact that there has been an increase in the initiatives taken by the governments, health ministries and bodies governing healthcare facilities in order to provide good quality treatment facilities to the patients and in turn effectively contain the spread of diseases.
Segmentation
However, the lack of complete awareness and the technical know-how of the effective methods that are needed to efficiently disinfect the surroundings and sterilize the instruments to be used in the operative procedures on different individuals poses a serious health problem and puts other at risk, thereby acting as a limiting factor in the market growth over the forecast period.
Furthermore, the market players are increasingly participating and involved in the market through top-quality and enhanced product offerings in order to cater to the rising demand among the consumers effectively and to contribute to the growth of the market over the forecast period. For instance, B. Braun Melsungen AG, one of the companies dealing in the provision of and based in offering their range of infection control products. They offer products under the “Fast-acting alcoholic disinfectant” and “Fixed surface disinfectant”, which are a part of their Surface Disinfectant product line. The fast-acting alcoholic disinfectant product is called the “Meliseptol Foam pure” and is designed to be a pure hospital disinfectant for surfaces that are fixed and non-critical articles, which are able to show a broad spectrum of antimicrobial action. Some of the other features of this product are, that s is ready to use for all the safety and medical equipment, it is active against the bacteria, mycobacteria, fungi, viruses such as HIV, HBV or HCV, adenovirus, noro-polyomavirus and rotavirus. The product “Virkon” is sold under the fixed surface disinfectant and is advised to be used at 1%. The product is designed with a unique formula, is in powder form and is able to facilitate the effective removal of organic matter and bacteria and is also capable to clean the bodily fluids and cleans up to 99.99% microorganisms.
Disinfectant to show notable growth
Disinfectants are expected to hold a significant market share and show notable growth over the forecast period. This is attributable to the fact that there has been an increase in the initiatives taken by the governments, health ministries and bodies governing healthcare facilities in order to provide good quality treatment facilities to the patients and in turn effectively contain the spread of diseases.
Segmentation
- By Product
- Disinfectant
- Sterilization
- Low-Temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End-User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. BRAZIL INFECTION CONTROL MARKET BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. BRAZIL INFECTION CONTROL MARKET BY END-USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE INTELLIGENCE
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANIES MENTIONED
8.1. 3M
8.2. Dr?gerwerk AG & Co. KGaA
8.3. Getinge AB
8.4. B. Braun Melsungen AG
8.5. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. BRAZIL INFECTION CONTROL MARKET BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. BRAZIL INFECTION CONTROL MARKET BY END-USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE INTELLIGENCE
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANIES MENTIONED
8.1. 3M
8.2. Dr?gerwerk AG & Co. KGaA
8.3. Getinge AB
8.4. B. Braun Melsungen AG
8.5. List is not Exhaustive*
